In a controversial move, a vaccine advisory panel recommends removing thimerosal from flu vaccines despite studies showing its benefits. Discover the implications for public health and vaccine safety.
A new monoclonal antibody called clesrovimab has been recommended for infants to prevent RSV, stirring debate among health experts and advocates. The FDA approved the treatment just weeks ago.
In a pivotal vote, the CDC's advisory committee has recommended the use of clesrovimab, a new monoclonal antibody, for infants under eight months to combat RSV, marking a significant advancement in public health.
At the NATO summit, Trump declared the Israel-Iran war likely over, attributing the ceasefire to U.S. airstrikes. Meanwhile, economic optimism among business leaders has plummeted amidst ongoing geopolitical tensions.
In a surprising turn of events, Dr. Michael Ross has withdrawn from the vaccine advisory panel after a conflict of interest review revealed ties to private healthcare companies. This comes amidst ongoing scrutiny of the committee’s integrity.
In a bold move, Health Secretary Robert F. Kennedy Jr. announces eight new members to the CDC's vaccine advisory committee, some of whom have previously criticized vaccines, raising eyebrows and concerns about future recommendations.
In a controversial move, Health Secretary Robert F. Kennedy Jr. has replaced all members of the CDC's vaccine advisory panel with eight new appointees, raising concerns among public health advocates about potential anti-vaccine bias.
In a bold and controversial move, Health Secretary Robert F. Kennedy Jr. has dismissed the entire vaccine advisory panel, raising concerns about the future of immunization recommendations and public health trust.
HHS Secretary Robert F. Kennedy Jr. has dismissed the entire vaccine advisory panel, citing conflicts of interest. This unprecedented move raises concerns about vaccine safety and public health integrity.
In a surprising move, Health Secretary Robert F. Kennedy Jr. has dismissed all members of a key vaccine advisory panel, raising concerns about public trust in immunizations. This drastic change could reshape vaccine policy in the U.S.
